Drive your heart,
Power your life.
Investor News

Fitipower's board of directors’ resolution for issuing common shares by private placement through cash capital injection

2024-04-18
Share

1.Date of the board of directors resolution:2024/04/18

2.Types of securities privately placed:Common shares

3.Counterparties for private placement and their relationship with

the Company:

  The counterparties for this private placement shall meet the

  qualifications for specific persons listed in Article 43-6 of the

  Securities and Exchange Act, and the letter No. 1120383220 dated

  September 12, 2023 issued by FSC, so as to be limited to strategic

  investors, prioritizing those who could benefit the Company’s

  long-term development, competitiveness, and rights of existing

  shareholders.

  So far, the counterparties for this private placement still need to be

  determined.

4.Number of shares or bonds privately placed:

  No more than 10,000 thousand shares.

5.Amount limit of the private placement:

  Within the limit of 10,000 thousand common shares, it is proposed to

  authorize the board of directors to conduct once or several times

  within a year after the resolution of shareholder meeting.

6.Pricing basis of private placement and its reasonableness:

  (1)The price of the private placement shares shall be no less than 80

     percent of the higher of the following:

     A.The average closing price of the Company's common shares for one,

       three, or five business days immediately preceding its price

       determination date, and adjusted by the applicable stock dividends,

       cash dividends and/or capital reduction.

     B.The average closing price of the Company's common shares for the

       thirty business days immediately preceding its price determination

       date, and adjusted by the applicable stock dividends, cash

       dividends, and/or capital reduction.

  (2)It is proposed that the actual price determination date and actual

     issuance price of privately placed common shares be submitted to the

     shareholders’ meeting for approval, and the board of directors be

     authorized to fix it within the range of not less than the percentage

     approved by resolution at the shareholders’ meeting, depending on

     future market conditions and the selection of strategic investors.

  (3)The above-mentioned basis for private placement pricing is in line

     with the “Directions for Public Companies Conducting Private

     Placements of Securities”, and considering the future outlook of the

     Company and the fact that there are strict restrictions on the timing,

     target and quantity of the transfer of the private placement of

     securities, and that the Company is not allowed to file to the

     competent authorities for supplemental public offering and listing

     within the three years after delivery, in addition to factors such as

     lower liquidity, the private placement pricing in this case should be

     reasonable.

7.Use of the funds raised in this private placement:

  The fund raise hereby shall server to support the funding need of future

  strategy development, which can efficiently strengthen the Company’s

  financial structure, improve the working performance and increase the

  competitiveness of the Company.

8.Reason for conducting non-public offering:

  Compare to public offering, privately placed securities cannot be freely

  traded within three years, can ensure the long-term cooperation between

  the Company and strategic investors, and authorizing the board of

  directors to conduct private placement according to the Company’s

  actual business needs effectively increases flexibility and freedom for

  fundraising.

9.Objections or qualified opinions from independent directors:None

10.Actual price determination date:NA

11.Reference price:NA

12.Actual private placement price, and conversion or subscription price:NA

13.Rights and obligations of these new shares privately placed:

  The rights and obligations of this private placement of common shares

  are the same as those of the Company’s issued common shares, except

  that, pursuant to Article 43-8 of the Securities and Exchange Act, the

  securities issued in this private placement shall not be freely

  transferable within three years after delivery, except under certain

  circumstances as provided by law. The Company intends to make a

  supplemental public offering and apply for the listing (TWSE) trading

  of the private placement of securities to the competent authorities in

  accordance with the relevant laws and regulations three years after the

  delivery of the private placement of negotiable securities.

14.Record date for any additional share exchange, stock swap,

or subscription:NA

15.Possible dilution of equity in case of any additional share exchange,

stock swap, or subscription:NA

16.For additional share exchange or subscription, possible influence of

change in shareholding ratio of TWSE-listed common shares if all privately

placed corporate bonds are converted and shares subscribed for (no.of TWSE -

listed common shares (A), (A) / common shares issued):NA

17.Please explain any countermeasures for lower circulation in shareholding

if the aforesaid estimated no.of TWSE -listed common shares does not reach

60million and the ratio does not reach 25%:NA

18.Any other matters that need to be specified:

  (1)The selection of subscribers will be based on the principle that

     there will be no major changes in management rights.

  (2)Should any revision to major matters regarding common stocks through

     private placement be made due to a competent authority or a change

     of the objective circumstance, excluding the price determination

     ratio, but including the issuance terms and conditions, the issuance

     price, the issuance shares, the total raising capital, the project

     items and progress, the expected use of funds, the expected efficacy

     and any other related matters, it is proposed at the shareholders’

     meeting that authorization be granted to the board of directors to

     exercise its full discretion in accordance with the prevailing market

     conditions.

  (3)This case is proposed to be submitted to shareholders' meeting for

     approval after the resolution of the board of directors.

Close